Physician profile
Vijian Dhevan
NPI 1003015421
$5,913.33
in general payments reported to CMS, 2019-2025
11 companies · $82.23 in 2025
The $82.23 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $128 · 2021: $1,247 · 2022: $2,430 · 2023: $997 · 2024: $853 · 2025: $82.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,159 · Education: $500 · Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,158.78 |
| Education | $500.00 |
| Food and Beverage | $273.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,837.67 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $1,281.96 | 2022-2025 | Intrabeam, Intrabeam 600 |
| Karl Storz Endoscopy-America | $852.86 | 2024 | |
| Medical Device Business Services, INC. | $329.85 | 2022 | |
| Ethicon US, LLC | $253.84 | 2020-2022 | |
| Baxter Healthcare | $176.14 | 2019 | |
| Lilly USA, LLC | $85.15 | 2022 | |
| Endogastric Solutions, INC | $34.00 | 2023 | Esophyx |
| Davol INC. | $23.50 | 2025 | Phasix Mesh |
| Medtronic, INC. | $19.97 | 2023 | Signia |
| Innocoll Pharmaceuticals Limited | $18.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijian Dhevan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.